Login
Annotated Medicine and Device Lists
Home
Annotated Medicine and Device Lists
PAHO Strategic Fund Medicine List
/ Dolutegravir + lamivudine + tenofovir
Dolutegravir + lamivudine + tenofovir
Tablet
50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil)
This medicine is present in:
List
Section
Observation
WHO Model List of Essential Medicines (2021)
6.4.2.5 Fixed-dose combinations of antiretroviral medicines
No observations
PAHO Strategic Fund Medicine List
2.6.1. Antiretrovirals
No observations
Information Resources:
Dolutegravir + lamivudine + tenofovir
Scientific Production
Evaluation Reports
Marketed Drugs
Medicine Evidences Summaries
Loading ...
Loading ...
Loading ...
No information available